Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
Breast Cancer Research and Treatment|December 3, 2005
Gene expression patterns for doxorubicin (Adriamycin) and cyclophosphamide (cytoxan) (AC) response and resistanceSusan Cleator, Anna Tsimelzon, Alan Ashworth, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 29, 2008
Ductal carcinoma in situ and the emergence of diversity during breast cancer evolutionD Craig Allred, Yun Wu, Sufeng Mao, et al.
Breast Cancer Research and Treatment|July 28, 2011
A phase II neoadjuvant trial of anastrozole, fulvestrant, and gefitinib in patients with newly diagnosed estrogen receptor positive breast cancerSuleiman Massarweh, Yee L Tham, Jian Huang, et al.
Breast Cancer Research and Treatment|May 15, 2016
ESR1 mutations affect anti-proliferative responses to tamoxifen through enhanced cross-talk with IGF signalingLuca Gelsomino, Guowei Gu, Yassine Rechoum, et al.
Plos One|January 10, 2013
SRC-2 coactivator deficiency decreases functional reserve in response to pressure overload of mouse heartErin L Reineke, Brian York, Erin Stashi, et al.
Lancet (London, England)|August 9, 2003
Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancerJenny C Chang, Eric C Wooten, Anna Tsimelzon, et al.
Journal of the National Cancer Institute|March 31, 2011
Loss of Rho GDIα and resistance to tamoxifen via effects on estrogen receptor αInes Barone, Lauren Brusco, Guowei Gu, et al.
Cancer Research|February 3, 2016
HER2 Signaling Drives DNA Anabolism and Proliferation through SRC-3 Phosphorylation and E2F1-Regulated GenesBryan C Nikolai, Rainer B Lanz, Brian York, et al.
Pageof 6